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Thirty-one patients with systemic candidiasis at postmortem examination 
were found to have Candida involvement of the myocardium without 
valvulitis. Retrospective examination of their clinical course demonstrated 
that a new conduction disturbance was seen in 10, supraventricular ar- 
rhythmias in 5, QRS changes mimicking myocardial infarction in 3, and 
pronounced T wave changes in 13. Hypotension or shock was seen in 13 
patients and could not be explained by coexistent bacteremia or blood 
loss in 8. One patient died suddenly. Of 19 patients with systemic candi- 
diasis without myocardial invasion, 4 had minor T wave changes and one 
had a supraventricular arrhythmia. Candida invasion of the heart signifi- 
cantly complicates the clinical course in systemic candidiasis and should 
be suspected when a young person without preexistent heart disease has 
cultures positive for a Candida organism, a significant arrhythmia, con- 
duction disturbance or other dramatic QRS change. The effect of therapy 
on Candida invasion of the heart is unknown. 
Involvement of the heart by Candida organisms is being recognized more 
often than in the past. Although Candida endocarditis on prosthetic 
heart valves has received the most attentioql direct involvement of the 
myocardium by Candida organisms without cardiac valve involvement 
has received little attention. The recognition of complete atrioventricular 
(A-V) block secondary to an abscess of the interventricular septum 
caused by Candida albicans reported from this institution2 prompted 
an analysis of the problem of Candida myocarditis without valvulitis. 
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Autopsy protocols for the years 1959 to 1974 at the University of Michigan 
Medical Center were examined for evidence of systemic candidiasis. From 
January 1959 through August 1972 only slide material was available for reex- 
amination. From September 1972 through December 1974, each case of systemic 
candidiasis was reviewed with particular attention to involvement of the myo- 
cardium. All cases were then assigned to either Group I, those with myocardial 
involvement, or Group II, those without such involvement, as determined mi- 
croscopically. Cases in which myocardial involvement was coexistent or secon- 
dary to involvement of the valves were excluded. In verified cases the clinical 
course, serial clinical cardiac observations, electrocardiograms, chest roent- 
genograms and autopsy material were assessed. The pathologic material was 
reviewed with specific attention to (1) distribution of mycotic lesions in the heart, 
(2) extent of involvement of other organ systems, and (3) underlying illness. 
Results 
Group I (Cases With Myocardial Involvement) 
Thirty-one patients with Candida involvement of the heart were iden- 
tified. Twenty cases were noted in the 14 years from 1959 through 1972, 
and 11 additional cases in the 2 years from 1973 through 1974 (Table I). 
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There were 20 male and 11 female subjects. The mean 
age at death was 35 years. 
Associated cardiac disease: Three patients had 
cardiac disease before the terminal illness. One had 
hypertensive heart disease with left bundle branch 
block and an old myocardial infarction at autopsy. A 
second patient had rheumatic heart disease and had a 
mitral valve prosthesis 2 weeks before death. At post- 
mortem examination the prosthesis and adjacent 
myocardium were free of infection but focal myocardial 
abscesses were noted. Blood cultures were positive for 
Candida, but the source of the infection was unknown. 
Neither patient had a new conduction disturbance or 
arrhythmia during the terminal illness. One other pa- 
tient had Libman-Sacks involvement of the mitral valve 
at autopsy. Two patients were receiving digitalis and 
had mild T wave abnormalities consistent with use of 
this agent. No electrolyte or acid-base disorders coin- 
cided with the appearance of the electrocardiographic 
abnormalities. 
Predisposing illness: Most patients had been 
chronically ill for several months before the terminal 
illness. More than half the patients spent part or all of 
the terminal illness in an acute care facility where con- 
tinuous monitoring was carried out. Almost all had 
multiple indwelling intravenous catheters at the time 
of death. Antibiotic agents were being given to 27 pa- 
tients and antineoplastic drugs to 9; 16 were receiving 
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corticosteroids; 11 had undergone a major operative 
procedure within 2 months of death; 6 had had a minor 
operative procedure (peritoneal dialysis, arterial shunt, 
skin graft, among others) within 1 month of death. Ten 
patients had blood dyscrasias such as leukemia or 
aplastic anemia; two had solid tissue neoplasm and two 
had body burns. Three infants had neonatal illnesses 
(enterocolitis, malabsorption syndrome) (Table I). 
Severe hypotension or shock complicated the clinical 
course in 13, but in 5 no bacteremia was present. In six 
patients with shock, neither bacteremia nor blood loss 
was present at the time of shock. One patient died 
suddenly and unexpectedly. Other modes of death in- 
cluded renal and hepatic failure, gastrointestinal 
hemorrhage and central nervous system lesions. 
Electrocardiographic findings: An electrocardi- 
ogram was obtained in 22 patients during the terminal 
illness. That of only one patient, a neonate, was entirely 
normal. Thirty-nine distinct electrocardiographic ab- 
normalities were seen in the remaining 21 patients 
(Table II). T wave abnormalities were the most com- 
monly encountered change and were often dramatic, 
acute in onset and evolutionary. A major new intra- 
ventricular or A-V conduction disturbance was seen in 
10 patients (excluding the patient with old left bundle 
branch block), and 5 experienced supraventricular ar- 
rhythmias; 3 patients had new QRS changes mimicking 
myocardial infarction. Despite the dominant left ven- 
tricular myocardial involvement with either focal lesions 
or multiple microabscesses in all patients, only one 
patient had ventricular premature beats. 
Review of chest roentgenograms was not helpful in 
defining the cardiac problems encountered. Most pa- 
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1 NO electrocardiogram available during 
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2 Normal 
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4 Supraventricular arrhythmia 
5 Left bundle branch block 
6 Nonspecific intraventricular conduc- 
tion delay 
7 QRS changes (without S-T elevation) 
mimicking anterior myocardial 
infarction 
8 lo A-V block 
9 Complete A-V block 
10 Left anterior fascicular block 
11 Right bundle branch block with left 
anterior fascicular block 
12 Premature ventricular contractions 














“Only new electrocardiographic findings are noted. Twenty-two 
patients in Group I had electrocardiograms during the terminal ill- 
ness. The abnormalities are not mutually exclusive. 
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pulmonary disease; however, because portable radio- 
graphic equipment was frequently used, estimation of 
heart size and changes in pulmonary vascularity were 
difficult to assess. 
Group II (Cases Without Myocardial Involvement) 
Nineteen patients with systemic candidiasis without 
myocardial involvement were identified according to 
the following criteria: positive ante- or post-mortem 
blood cultures, or microscopic identification of typical 
organisms located in major organs, excluding the res- 
piratory tract, gastrointestinal tract and urinary blad- 
der. The underlying illness, age of patient at death, and 
the organism recovered were comparable with findings 
in Group I (Table I). There were 10 male and 9 female 
subjects. The mean age at death was 39 years. 
Of the available electrocardiograms 40 percent were 
completely normal, a distinct difference from findings 
in Group I. Only one major arrhythmia, a transient 
episode of atria1 flutter with variable block, was noted. 
This occurred 2 weeks before death. No other arrhyth- 
mia or major conduction defect occurred in this group. 
Two of the four patients with minor T wave changes 
FIGURE 1. Section of left ventricle with multiple gray nodules (arrows) 
representing Candida myocardial abscesses. 
were receiving digitalis; no reason could be found for the 
minor T wave changes in the other two. 
Pathologic Findings 
Necropsy demonstrated myocardial abscesses in all 
31 cases of Group I. In only seven were gross lesions 
evident. These consisted of palpable nodules randomly 
distributed in either ventricle, although most prominent 
in the left ventricle (Fig. 1). Depending on the age of the 
lesion, these consisted of 3 to 15 mm white to yellow 
nodules; in two cases a hyperemic border was evident. 
A fibrinous pericarditis in various stages of organization 
was present in 10 cases. In five cases, Candida yeast 
forms were found. 
Histologic examination demonstrated microcolonies 
of yeast cells forming pseudohyphal extensions in ra- 
diating patterns, best identified by silver-methenamine 
or periodic acid-Schiff reaction (Fig. 2). The extent of 
the inflammatory reaction varied-from complete ab- 
sence to well developed acute suppuration-depending 
upon the patient’s underlying disease and immune and 
cell response capabilities (Fig. 3). The microcolonies 
infiltrated the endomesial interstitial tissue, spreading 
FIGURE 2. Left ventricular myocardium containing a microabscess 
stained with silver-methenamine to demonstrate pseudohyphal ex- 
tensions of Candida. (Silver methenamine X 285, reduced by 28 per- 
cent.) 
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the myocardial fibers. The intervening myocardial fi- 
bers exhibited coagulative necrosis; in some cases, de- 
pending upon the inflammatory response, central li- 
quification necrosis formed an abscess. Invasion into 
blood vessels by pseudohyphae occurred, as is com- 
monly found with aspergillus infections (Fig. 4). This 
invasion could, in turn, cause local thrombosis within 
the arteriole itself, or result in progression of the in- 
flammatory process by embolization of the organisms 
to other areas of the myocardium. Inflammation was 
restricted to the focal lesion and diffuse myocarditis was 
not found. 
The distribution of lesions to the right or left heart 
chambers was random, as expected with a septicemic 
origin, with localizations in mural, epicardial and sub- 
endocardia! foci. In one case abscesses caused by Can- 
dida organisms were found in the conduction sys- 
tem.2 
In only one case were Candida abscesses restricted to 
the myocardium and systemic involvement not evident. 
Focal lesions were present in the kidneys (19 cases), 
gastrointestinal tract (12 cases), lungs (14 cases), brain 
(6 cases), liver (6 cases), and thyroid (4 cases). A gas- 
trointestinal lesion was found in 21 of the 31 cases. 
Candida forms were found as either mycotic plaques or 
within ulcerative processes. 
In 19 of 24 cases with postmortem blood cultures 
Candida yeast forms were demonstrated. 
Discussion 
Incidence: Candida involvement of the heart is fre- 
quently noted at postmortem examination in patients 
with systemic candidiasis.4-g Of interest is that Candida 
myocarditis had not been described in the era before the 
extensive utilization of antibiotic and immunosup- 
pressive agents in clinical practice.” There does not 
appear to be any doubt that the frequency of Candida 
infections is increasing, particularly in patients with 
blood dyscrasias.4Tg 
The reported prevalence of cardiac involvement with 
Candida organisms in patients with systemic candidiasis 
varies; recent reviews indicate that at least 10 percent’ 
and possibly 63 percent of patient8 have cardiac in- 
volvement. Our data are consistent with the higher 
figure; 31 of 50 patients (62 percent) at our institution 
with systemic candidiasis had myocardial involvement 
at postmortem examination. Heretofore, the clinical 
significance of this involvement was unknown because 
FIGURE 3. Myocardium containing a microabscess. A lymphocytic and 
plasma cell response to proliferating Candida organisms is evident. 
Coagulative necrosis of myocardial fibers is present at the margins of 
the abscess. (Hematoxylin-eosin X 120, reduced by 28 percent.) 
FIGURE 4. Intramural coronary artery with Candida pseudohyphal in- 
growth. No inflammatory reaction is present in this patient with im- 
mune-suppression. (Hematoxylin-eosin X 100, reduced by 28 per- 
cent.) 
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there has been no detailed analysis of the clinical course 
of these patients. Our data indicate that major con- 
duction disturbances and clinically significant ar- 
rhythmias result from this involvement. 
Cause of hypotension and shock: There are three 
possible explanations for the hypotension observed in 
our patients. It may have been due to endotoxic shock 
from coexistent bacteremia. Septicemia was thought to 
be present in several patients, but shock often occurred 
in the absence of gram-negative bacteremia. Although 
it is possible that hypotension could have resulted from 
myocardial invasion causing localized or generalized 
impairment of myocardial contractility, this origin 
seems unlikely because most patients had small or even 
only microscopic areas of myocardial involvement. The 
clinical absence of pulmonary edema also makes this 
explanation unlikely. It is more likely that hypotension 
resulted from the release of an endotoxin-like material 
from the Candida organisms, causing a syndrome pa- 
thophysiologically similar to bacteremic endotoxic 
shock. 
Several studieslo-l2 have demonstrated that Candida 
species possess a material similar to bacterial endotoxin 
capable of producing clinical findings similar to those 
of bacteremic endotoxic shock. It would appear that 
substantially greater quantities of the fungal product 
than the bacterial product are necessary to produce a 
similar reaction.12 
Clinical Implications 
Our patients differ markedly in all respects from 
those with Candida endocarditis after intracardiac 
operative pr0cedures.l Only one of our patients had an 
antecedent cardiac operation. None had new murmurs, 
gallop sounds, signs of pulmonary edema or embolic 
phenomena. More than half were immunologically 
compromised, either by their primary illness or by 
therapy for it. Nineteen of 31 patients with myocardial 
involvement were receiving either corticosteroids or 
antineoplastic agents or both; 27 were receiving one or 
more antibiotic agents before recovery of the Candida 
organism. 
Although it is not uncommon to recover Candida 
species from hospitalized patients (0.8 percent of all 
specimens submitted to one bacteriology laboratoryl:i), 
systemic candidiasis is implicated in very few cases. The 
death rate in patients with Candida septicemia with 
systemic candidiasis approaches 100 percent. In our 
series, as in others, the patients came from many dif- 
ferent services of a general hospital; many had in- 
dwelling urinary and intravenous catheters and many 
had received blood transfusions and had minor or major 
operative procedures. 
The electrocardiographic changes described are in no 
way specific for Candida myocarditis and are similar to 
those described by Fine et a1.l” in a review of electro- 
cardiographic changes in myocarditis of any origin. 
Their study also demonstrated that fever as such rarely 
caused even subtle electrocardiographic changes. 
Treatment and diagnosis: Only two patients in this 
series were treated for systemic candidiasis, and one 
received only 6 mg of Amphotericin B before death. In 
a third patient the decision to institute therapy was 
made just before death. The rarity of premortem diag- 
nosis and timely treatment is surprising because 22 
patients had positive sputum, blood or wound cultures 
during their hospital course. The difficulties of selecting 
treatment for patients with positive cultures for Can- 
dida species have been outlined by several au- 
thors.l,14,1” 
Myocardial involvement with the Candida organism 
should be strongly considered when a patient with 
positive blood, urine or sputum culture for Candida has 
a major intraventricular or A-V conduction defect, new 
QRS changes or an arrhythmia. In fact, with only one 
exception these new electrocardiographic changes were 
found to be specific for this. New T wave changes in the 
absence of digitalis appear to be a sensitive but less 
specific indicator of myocardial Candida involvement. 
Inasmuch as ischemic heart disease, electrolyte dis- 
turbances, acid-base disorders and some drugs may 
produce some of the electrocardiographic changes seen 
here, the degree of suspicion for Candida myocarditis 
in the patient with systemic candidiasis should be 
greatest when electrocardiographic changes are seen in 
the younger patient without preexistent heart disease 
or other known causes of the electrocardiographic ab- 
normalities. 
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